Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > Trump begins mass layoffs at FDA, CDC, other US health agencies
    Headlines

    Trump begins mass layoffs at FDA, CDC, other US health agencies

    Published by Global Banking & Finance Review®

    Posted on April 1, 2025

    4 min read

    Last updated: January 24, 2026

    Trump begins mass layoffs at FDA, CDC, other US health agencies - Headlines news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    The Trump administration has initiated mass layoffs at US health agencies, affecting 10,000 staffers, as part of a downsizing plan, raising concerns about public health responses.

    Trump Starts Major Layoffs at FDA, CDC, and Health Agencies

    By Leah Douglas and Marisa Taylor

    WASHINGTON (Reuters) -The Trump administration began mass layoffs of 10,000 staffers at U.S. health agencies on Tuesday, according to multiple sources familiar with the situation, with security guards barring entry to some employees just hours after they received dismissal notices.

    The cuts, which affect several high-profile agencies under the Department of Health and Human Services, including the FDA, CDC and the National Institutes of Health, are part of a broad plan by President Donald Trump and billionaire ally Elon Musk to shrink the federal government and slash spending.

    Health Secretary Robert F. Kennedy Jr. has described the cuts as essential to streamlining a bloated bureaucracy.

    However they have included the ouster of top scientists overseeing public health, cancer research and vaccine and drug approvals, raising concerns about how the U.S. will respond to health emergencies, such as the ongoing measles outbreak and spreading bird flu.

    Departures at the Food and Drug Administration, considered the world's top drugs regulator, included Peter Stein, the director of the Office of New Drugs in its Center for Drug Evaluation and Research division. He resigned on Tuesday when faced with being fired, according to one source familiar with the matter.

    Brian King, the head of the FDA's Center for Tobacco Products division, was fired, according to an email sent by King to FDA staff seen by Reuters. That followed the ouster of Peter Marks, the FDA's highly regarded top vaccine official.

    Staff have also been leaving and some employees reviewing products say they are struggling to meet their deadlines.

    "The FDA as we've known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed," former Commissioner Robert Califf wrote in a LinkedIn post.

    "I believe that history will see this a huge mistake," he wrote. "It will be interesting to hear from the new leadership how they plan to put 'Humpty Dumpty' back together again."

    TURNED AWAY AT DOORS

    An FDA employee said staff had to present their badges at the building entrance and those who had been fired were given a ticket and told to return home, according to one source. People waited in line for hours not knowing what would happen when they reached the front.

    The ticket, seen by Reuters, listed phone numbers for 10 different departments for employees to call to retrieve their "essential" equipment.

    An FDA staff member said 17 employees in the press office were let go. FDA's Chief Information Officer Vid Desai said he was also let go.

    Fired staff received emails that said their terminations did not reflect on their service, performance or conduct, according to an email seen by Reuters.

    Cuts at the FDA's Center for Tobacco Products included the Office of Management and Office of Regulations in their entirety, said the center's former director, Mitch Zeller, citing a contact still at the center.

    "I think that this makes it virtually impossible for CTP to regulate tobacco products," Zeller said.

    LONG LINES

    A line of cars clogged the two main roads leading into the National Institutes of Health's main campus in Bethesda, Maryland, where employees had been notified early Tuesday morning that they were laid off, according to a source.

    At the Centers for Disease Control and Prevention, staff who were fired had worked at the National Center for Environmental Health, Substance Abuse and Mental Health Services Administration, and the National Center for Immunization and Respiratory Diseases, including at least one person working on the federal response to measles outbreaks, according to another source.

    "What I think is clear and that people should understand is that HHS touches the lives of just about every American and a reorganization and downsizing of this size would typically take months on months of work," said Kevin Griffis, who resigned on March 21 as CDC Director of Communications.

    A health official said employees who worked directly for HHS also were fired. HHS officials were not immediately available for comment.

    The line to get into the Rockville, Maryland HHS building that houses the Health Resources and Services Administration, the Substance Abuse and Mental Health Services Administration, the Agency for Healthcare Research and Quality, and the Indian Health Service stretched all the way to the parking lot, two sources told Reuters, with only two security guards on site screening everyone attempting to enter.

    (Additional reporting by Dan Levine in San Francisco; Chad Terhune in Los Angeles; Julie Steenhuysen in Chicago; Rachael Levy, Ted Hesson and Ahmed Aboulenein in Washington; Patrick Wingrove, Michael Erman and Nathan Layne in New York; and Emma Rumney in London; Editing by Caroline Humer, Frances Kerry, Deepa Babington and Bill Berkrot)

    Key Takeaways

    • •Trump administration lays off 10,000 health agency staff.
    • •FDA, CDC, and NIH affected by the cuts.
    • •Layoffs part of a plan to reduce government size.
    • •Concerns raised over public health response capabilities.
    • •Key FDA and CDC officials among those dismissed.

    Frequently Asked Questions about Trump begins mass layoffs at FDA, CDC, other US health agencies

    1What is the main topic?

    The article discusses mass layoffs at US health agencies initiated by the Trump administration.

    2Who are affected by the layoffs?

    The layoffs affect 10,000 staffers at the FDA, CDC, and NIH.

    3Why are these layoffs happening?

    The layoffs are part of a plan to shrink the federal government and reduce spending.

    More from Headlines

    Explore more articles in the Headlines category

    Image for Slovak prosecutor ends probe over fighter jets, air defence systems donated to Ukraine
    Slovak prosecutor ends probe over fighter jets, air defence systems donated to Ukraine
    Image for Olympics-No credible threats to Milano Cortina Games, U.S. security official says
    Olympics-No credible threats to Milano Cortina Games, U.S. security official says
    Image for Elton John's husband accuses Daily Mail of homophobia in UK privacy trial
    Elton John's husband accuses Daily Mail of homophobia in UK privacy trial
    Image for World Economic Forum investigates its CEO over Epstein links
    World Economic Forum investigates its CEO over Epstein links
    Image for Ukraine says Starlink terminals used by Russia deactivated in blow to Moscow
    Ukraine says Starlink terminals used by Russia deactivated in blow to Moscow
    Image for Novo Nordisk CEO says Hims $49 compounded Wegovy pill a 'waste' of money
    Novo Nordisk CEO says Hims $49 compounded Wegovy pill a 'waste' of money
    Image for Exclusive-ECB to widen access to euro loans in bid to boost global role, sources say
    Exclusive-ECB to widen access to euro loans in bid to boost global role, sources say
    Image for Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding
    Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding
    Image for Germany to require streaming platforms to invest in local production
    Germany to require streaming platforms to invest in local production
    Image for US cuts contact with Polish parliament speaker over Trump 'insults'
    US cuts contact with Polish parliament speaker over Trump 'insults'
    Image for Analysis-Once feted Mandelson becomes nightmare for weakened UK PM Starmer
    Analysis-Once feted Mandelson becomes nightmare for weakened UK PM Starmer
    Image for ECB's Lagarde to raise reform pressure on EU leaders with checklist
    ECB's Lagarde to raise reform pressure on EU leaders with checklist
    View All Headlines Posts
    Previous Headlines PostLooming trade tariffs have yet to hit demand for flights, Walsh says
    Next Headlines PostUkraine power imports rise 11% in March, consultancy says